The system can lock its payload in place and control how it is released
A new injectable material designed to deliver drug therapies and sensor technology to targeted areas within the human body is being developed by a Texas A&M University biomedical engineer who says the system can lock its payload in place and control how it is released.
The research, led by Michael McShane, professor in the Department of Biomedical Engineering who specializes in biomaterials, and graduate student Jason Roberts, appears in “Journal of Materials Chemistry B.” It details the development of a carrier system embedded with microscopic capsules that act as tiny reservoirs for medicines or even sensors that would alert a person in critical instances, such as when blood-sugar levels change.
The technology, McShane notes, affords researchers a high degree of control over what is delivered to the body, where and when it is delivered and how much of it is delivered. That degree of flexibility, he says, could make the system an extremely useful tool when it comes to targeted drug delivery.
As opposed to having patients simply swallow a pill, health care professionals have long envisioned delivering specific quantities of medicines to targeted areas of the body, thereby increasing the treatment’s effectiveness while reducing side effects. In order to achieve this, a “vehicle” of sorts is needed to safely and accurately deliver the medicine to the desired location within the body.
McShane’s team, which also includes graduate student Dustin Ritter, is building that vehicle using a modified Jell-O-like substance known as a hydrogel. A hydrogel is a polymer mesh material that is typically biocompatible, meaning it allows cells within the body to conduct normal physiological processes without triggering an immune response from the host. Because of this, hydrogels are widely used in tissue engineering research, and they can be found in a number of other applications, most commonly as the material from which contact lenses are made.
Although hydrogels aren’t new, the ones employed in McShane’s carrier system aren’t typical; they’ve been enhanced. Specifically, they are embedded with tiny capsules that are significantly smaller than the width of a human hair. Each of these microcapsules serves as a reservoir or depot for the material doctors and researchers want to deliver, such as a drug.
Measuring a few microns in diameter, these porous microparticles are made from clusters of calcium carbonate nanoparticles that have been deliberately formed around a specific material to trap it inside, McShane notes. Once the desired material is trapped within the microsphere, multiple layers of polymers are wrapped around the particles, he explains. This allows for a precise and customizable control over how the microcapsule will release its contents when it interacts with its surrounding environment, McShane explains.
The system, McShane says, is not limited to drug delivery. In fact, it has shown promising results with biosensors. In these types of applications, he explains, the microcapsules carry a payload, such as a protein, that is responsive to something in the body that doctors want to measure. This measurable material is allowed to pass into the hydrogel and into the capsules where it triggers some type of optical change, he says. For example, McShane has been able to trigger a color change in the material (observable with a reader device) when pH and oxygen levels change or when blood-sugar levels fluctuate. It’s work that could translate into safer and more effective ways for people, such as those suffering from diabetes, to monitor their conditions.
The Latest on: Targeted drug delivery
via Google News
The Latest on: Targeted drug delivery
- miR-216a-targeting theranostic nanoparticles promote proliferation of insulin-secreting cells in type 1 diabetes animal modelon March 24, 2020 at 3:20 am
Theranostic nanodrugs can deliver therapeutics including small molecules, peptides, antibodies and oligonuceotides to targeted tissues, while imaging allows the non-invasive assessment of their ...
- South Milwaukee man charged with drug dealing, may be tied to overdose deathson March 20, 2020 at 7:32 am
... charged Thursday with delivery of three counts of delivery of narcotics and two counts related to possession or delivery of THC. According to the criminal complaint, Ihediwa was targeted for an ...
- Neuron-targeted electrical modulationon March 19, 2020 at 12:39 pm
Conductive polymers have been widely studied and used for biomedical applications—including as biosensors, neural prostheses, and bioactuators—and for drug delivery and tissue engineering (1 ... (2) ...
- Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.on March 19, 2020 at 12:52 am
The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View ...
- Lynparza granted orphan drug designation in Japan for BRCA-mutated metastatic pancreatic canceron March 19, 2020 at 12:07 am
This designation is an important step forward in bringing the first targeted ... accelerate the delivery of our strategy, as illustrated by the investment in Acerta Pharma in haematology. By ...
- Drug Device Combination Products Market Growth, Share, Demand and Applications Forecast to 2027on March 18, 2020 at 4:09 am
VALLEY COTTAGE, N.Y. - Drug device combination products are devices which consists medical device along with the pharmaceutical ingredient that helps to deliver the drug to desired location in the ...
- UAE scientists develop new targeted cancer treatmenton March 15, 2020 at 4:50 am
Attached to the surface of each nanoparticle is a small protein-like molecule called a peptide, which ensures the drug is absorbed by the tumour. So far, the new delivery method has only been tested ...
- Global Markets for Drug Delivery in Cancer, Forecast to 2028 - Includes Coverage on Antisense, RNAi and Gene Therapy for Canceron March 12, 2020 at 5:51 pm
The "Drug Delivery in Cancer - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
- Cardiovascular Drug Delivery Market Insights, 2018-2028 Featuring Profiles of 82 Companies and 80 Collaborationson March 12, 2020 at 7:21 am
/PRNewswire/ -- The "Cardiovascular Drug Delivery - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added ...
- Global Cardiovascular Drug Delivery Industry Landscape & Forecast to 2028on March 10, 2020 at 4:04 am
The "Cardiovascular Drug Delivery - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The cardiovascular drug delivery markets are ...
via Bing News